These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan. Sibley LD; Adams LB; Krahenbuhl JL Clin Exp Immunol; 1990 Apr; 80(1):141-8. PubMed ID: 2138940 [TBL] [Abstract][Full Text] [Related]
3. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Adams LB; Fukutomi Y; Krahenbuhl JL Infect Immun; 1993 Oct; 61(10):4173-81. PubMed ID: 8406806 [TBL] [Abstract][Full Text] [Related]
4. Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae. Sibley LD; Krahenbuhl JL Infect Immun; 1988 Aug; 56(8):1912-9. PubMed ID: 2840398 [TBL] [Abstract][Full Text] [Related]
5. Macrophage activation: lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha. Roach TI; Barton CH; Chatterjee D; Blackwell JM J Immunol; 1993 Mar; 150(5):1886-96. PubMed ID: 8436823 [TBL] [Abstract][Full Text] [Related]
6. Mycobacterium leprae-burdened macrophages are refractory to activation by gamma interferon. Sibley LD; Krahenbuhl JL Infect Immun; 1987 Feb; 55(2):446-50. PubMed ID: 3100449 [TBL] [Abstract][Full Text] [Related]
7. Opposing effects of interferon-gamma on iNOS and interleukin-10 expression in lipopolysaccharide- and mycobacterial lipoarabinomannan-stimulated macrophages. Roach TI; Barton CH; Chatterjee D; Liew FY; Blackwell JM Immunology; 1995 May; 85(1):106-13. PubMed ID: 7543444 [TBL] [Abstract][Full Text] [Related]
8. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. Schlesinger LS; Horwitz MA J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838 [TBL] [Abstract][Full Text] [Related]
9. Correlation between macrophage activation and bactericidal function and Mycobacterium leprae antigen presentation in macrophages of leprosy patients and normal individuals. Desai SD; Birdi TJ; Antia NH Infect Immun; 1989 Apr; 57(4):1311-7. PubMed ID: 2494115 [TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma independent formation of pulmonary granuloma in mice by injections with trehalose dimycolate (cord factor), lipoarabinomannan and phosphatidylinositol mannosides isolated from Mycobacterium tuberculosis. Takimoto H; Maruyama H; Shimada KI; Yakabe R; Yano I; Kumazawa Y Clin Exp Immunol; 2006 Apr; 144(1):134-41. PubMed ID: 16542375 [TBL] [Abstract][Full Text] [Related]
12. Lipoarabinomannan from Mycobacterium tuberculosis modulates the generation of reactive nitrogen intermediates by gamma interferon-activated macrophages. Anthony LS; Chatterjee D; Brennan PJ; Nano FE FEMS Immunol Med Microbiol; 1994 May; 8(4):299-305. PubMed ID: 8061654 [TBL] [Abstract][Full Text] [Related]
13. Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages. Bradbury MG; Moreno C Clin Exp Immunol; 1993 Oct; 94(1):57-63. PubMed ID: 8403518 [TBL] [Abstract][Full Text] [Related]
14. Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response. Briken V; Porcelli SA; Besra GS; Kremer L Mol Microbiol; 2004 Jul; 53(2):391-403. PubMed ID: 15228522 [TBL] [Abstract][Full Text] [Related]
15. Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. Flesch I; Kaufmann SH J Immunol; 1987 Jun; 138(12):4408-13. PubMed ID: 3108389 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway. Paulnock DM; Lambert LE J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906 [TBL] [Abstract][Full Text] [Related]
17. Restoration of lipopolysaccharide-mediated cytotoxic macrophage induction in C3H/HeJ mice by interferon-gamma or a calcium ionophore. Akagawa KS; Kamoshita K; Onodera S; Tokunaga T Jpn J Cancer Res; 1987 Mar; 78(3):279-87. PubMed ID: 3106284 [TBL] [Abstract][Full Text] [Related]
18. Establishment of murine macrophage hybridoma clones capable of acquiring tumoricidal activity upon activation with recombinant interferon-gamma and lipopolysaccharide. Kiyotaki C; Katagiri T; Tatsumi Y; Fujiwara H; Hamaoka T J Cancer Res Clin Oncol; 1987; 113(4):383-6. PubMed ID: 3110175 [TBL] [Abstract][Full Text] [Related]
19. Nitrotyrosine formation after activation of murine macrophages with mycobacteria and mycobacterial lipoarabinomannan. Venkataprasad N; Riveros-Moreno V; Sosnowska D; Moreno C Clin Exp Immunol; 1999 May; 116(2):270-5. PubMed ID: 10337018 [TBL] [Abstract][Full Text] [Related]
20. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Chan J; Fan XD; Hunter SW; Brennan PJ; Bloom BR Infect Immun; 1991 May; 59(5):1755-61. PubMed ID: 1850379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]